Shares in Axsome Therapeutics have rocketed on FDA approval ... to Johnson & Johnson's Spravato (esketamine), which was approved in March 2019 and is administered as a nasal spray twice a week ...

If you've been HBO’s new season of White Lotus, then you've seen Parker Posey’s character Victoria Ratliff popping a steady ...

Tesla boss Elon Musk seems to be on a mission to conquer the world, and even Mars. But his odd-hour rants, alleged Nazi ...

Johnson & Johnson has priced its new ... 25% and 52% cheaper to meet its value threshold. The spray – which was approved by the FDA in March – has a wholesale acquisition cost of $295 per ...

A month into his role as health and human services secretary, Robert F. Kennedy Jr.'s moves on vaccines have worried health ...

Kennedy has spoken more favorably about alternative remedies for measles, a disease for which there is no approved treatment ... president of the Robert Wood Johnson Foundation, a health-focused ...

KLOXXADO ® delivers 8 mg of naloxone hydrochloride per spray in a ready to use nasal spray to reverse the effects of opioid overdose.

Milestone Pharmaceuticals Inc. announced that the FDA has ... for its nasal spray CARDAMYST™ (etripamil), aimed at treating Paroxysmal Supraventricular Tachycardia (PSVT). If approved, Milestone ...

The US Food and Drug Administration (FDA) has approved the ... chronic rhinosinusitis with nasal polyps, chronic unexplained hives, and food allergies. The approval “will help broaden access ...

Johnson & Johnson's nipocalimab earns FDA Fast Track status for Sjögren's disease, speeding development and review for unmet medical needs.

Celltrion has launched Steqeyma (ustekinumab-stba), its biosimilar of Stelara (ustekinumab), at list price at an 85% discount ...